Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Bibtex

@article{e2b88f39ed534dc3a4e928a49792982e,
title = "Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)",
abstract = "To clarify the role of metabolic factors in endometrial carcinogenesis, we conducted a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC), and examined the relation between prediagnostic plasma lipids, lipoproteins, and glucose, the metabolic syndrome (MetS; a cluster of metabolic factors) and endometrial cancer risk. Among pre- and postmenopausal women, 284 women developed endometrial cancer during follow-up. Using risk set sampling, 546 matched control subjects were selected. From conditional logistic regression models, high-density lipoprotein cholesterol (HDL-C) levels were inversely associated with risk body mass index (BMI)-adjusted relative risk (FR) for top versus bottom quartile 0.61 (95{\%} confidence intervals (CI) 0.38-0.97), P-trend= 0.02). Glucose levels were positively associated with risk (BMI-adjusted RR top versus bottom quartile 1.69 (95{\%} Cl 0.99-2.90), P-trend, = 0.03), which appeared stronger among postmenopausal women (BMI-adjusted RR top versus bottom tertile 2.61 (95{\%} Cl 1.46-4.66), P-trend=0.0006, P-heterogeneity=0.13) and never-users of exogenous hormones (P-heterogeneity=0-005 for oral contraceptive (OC) use and 0.05 for hormone replacement therapy-use). The associations of HDL-C and glucose with risk were no longer statistically significant after further adjustment for obesity-related hormones. Plasma total cholesterol, Low-density lipoprotein cholesterol (LDL-C), and triglycerides were not significantly related to overall risk. The presence of MetS was associated with risk (RR 2.12 (95{\%} CI 1.51-2.97)), which increased with the number of MetS factors (P-trend=0.02). An increasing number of MetS factors other than waist circumference, however, was marginally significantly associated with risk only in women with waist circumference above the median (P-interaction=0-01). None of the associations differed significantly by fasting status. These findings suggest that metabolic abnormalities and obesity may act synergistically to increase endometrial cancer risk.",
author = "Cust, {Anne E.} and Rudolf Kaaks and Christine Friedenreich and Fabrice Bonnet and Martine Laville and Anne Tjonneland and Anja Olsen and Kim Overvad and Jakobsen, {Marianne Uhre} and Veronique Chajes and Frangoise Clavel-Chapelon and Marie-Christine Boutron-Ruault and Jakob Linseisen and Annekatrin Lukanova and Heiner Boeing and Tobias Pischon and Antonia Trichopoulou and Bamia Christina and Dimitrios Trichopoulos and Domenico Palli and Franco Berrino and Salvatore Panico and Rosario Tumino and Carlotta Sacerdote and Gram, {Inger Torhild} and Eiliv Lund and Quiros, {J. R.} and Nomie Travier and Garcia, {Carmen Martinez} and Nerea Larranaga and Maria-Dolores Chirlaque and Eva Ardanaz and G{\"o}ran Berglund and Eva Lundin and Bueno-De-Mesquita, {H. Bas} and Franzel, {J. B. van Duijnhoven} and Peeters, {Petra H. M.} and Sheila Bingham and Kay-Tee Khaw and Naomi Allen and Tim Key and Pietro Ferrari and Sabina Rinaldi and Nadia Slimani and Elio Riboli",
year = "2007",
doi = "10.1677/ERC-07-0132",
language = "English",
volume = "14",
pages = "755--767",
journal = "Endocrine-Related Cancer",
issn = "1479-6821",
publisher = "Society for Endocrinology",
number = "3",

}